Literature DB >> 6165740

Urinary excretion kinetics of hydroxyethyl starch 350/0.60 in normovolaemic man.

J M Mishler, C R Ricketts, E J Parkhouse.   

Abstract

Rates of urinary excretion concomitant with the molecular size distribution of filtered polymer fragments were determined in five normovolaemic men dosed with 30 g/m2 BSA of a species of HES (HES 350/0.60) possessing a M-W of 350 000 combined with an MS of 0.60. Approximately 13% of the total injected dose of HES 350/0.60 was excreted in urine 1 hr after dosing, and 45% by 72 hours. Gel filtration of Sepharose CL-4B revealed that aliquots of urine collected 1 hour after injection contained polymer fragments of HES 350/0.60 with values of Kav ranging between 0.88 and 0.84, and possessed a Stokes radius (r = 32A) similar to that of Dextran 20 (M-W 22 700). Polymer fragments of HES 350/0.60 excreted 6 to 48 hours after dosing, however, possessed a Kav ranging between 0.78 and 0.73 with a Stokes radius (r = 45A) similar to that of Dextran 40 (M-W 41 000). All filtered polymer fragments were less polydisperse relative to both the injection solution (Kav 0.60) and residual material recovered from blood immediately after injection (Kav 0.72). These data support the hypothesis that the excretion of HES 350/0.60 occurs in two distinct phases: a rapid phase of elimination dependent on the M-n of the injected solution, and a slower phase dependent on the MS (degree of resistance to alpha-amylase attack). This study, in conjunction with our previous investigation of the changes in circulating HES 350/0.60, define the basic differences between clearance and excretion of the dextrans and of the rapidly degraded species of HES. These data are relevant to the utilisation of HES 350/0.60 during centrifugal leucapheresis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165740      PMCID: PMC493291          DOI: 10.1136/jcp.34.4.361

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  THE RENAL CLEARANCE OF DEXTRAN OF DIFFERENT MOLECULAR SIZES IN NORMAL HUMANS.

Authors:  G ARTURSON; G WALLENIUS
Journal:  Scand J Clin Lab Invest       Date:  1964       Impact factor: 1.713

2.  Molecular weight distribution analysis by gel chromatography on Sephadex.

Authors:  K A Granath; B E Kvist
Journal:  J Chromatogr       Date:  1967-05

3.  Clinical trial of 6 per cent hydroxyethyl starch (a new plasma expander).

Authors:  T F Solanke
Journal:  Br Med J       Date:  1968-09-28

4.  A clinical physiologic study of hydroxyethyl starch.

Authors:  W Metcalf; A Papadopoulos; R Tufaro; A Barth
Journal:  Surg Gynecol Obstet       Date:  1970-08

5.  Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch.

Authors:  W L Thompson; T Fukushima; R B Rutherford; R P Walton
Journal:  Surg Gynecol Obstet       Date:  1970-11

6.  Plasma clearance and renal excretion of erythrocyte cryoprotectant hydroxyethylated amylopectin.

Authors:  J M Mishler; E S Parry; A Petrie
Journal:  Br J Haematol       Date:  1978-10       Impact factor: 6.998

Review 7.  Hydroxyethyl starch as an experimental adjunct to leukocyte separation by centrifugal means: review of safety and efficacy.

Authors:  J M Mishler
Journal:  Transfusion       Date:  1975 Sep-Oct       Impact factor: 3.157

8.  Post-transfusion survival of hydroxyethyl starch 450/0.70 in man: a long-term study.

Authors:  J M Mishler; C R Ricketts; E J Parkhouse
Journal:  J Clin Pathol       Date:  1980-02       Impact factor: 3.411

9.  A clinical study of low molecular weight-hydroxyethyl starch, a new plasma expander.

Authors:  J M Mishler; E S Parry; B A Sutherland; J R Bushrod
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

10.  Catabolism of low-molecular-weight hydroxyethylated amylopectin in man. I. Changes in the circulating molecular composition.

Authors:  J M Mishler; C R Ricketts; E J Parkhouse; H Borberg; R Gross
Journal:  J Lab Clin Med       Date:  1979-12
View more
  2 in total

Review 1.  Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies.

Authors:  Romuald Bellmann; Clemens Feistritzer; Christian J Wiedermann
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

2.  Investigation of urinary excretion of hydroxyethyl starch and dextran by uhplc-hrms in different acquisition modes.

Authors:  S Esposito; K Deventer; A J Giron; K Roels; L Herregods; A Verstraete; P Van Eenoo
Journal:  Biol Sport       Date:  2014-04-05       Impact factor: 2.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.